Identification of a novel IL-6 isoform binding to the endogenous IL-6 receptor (Q44045863)

29 November 2017

Identification of a novel IL-6 isoform binding to the endogenous IL-6 receptor (English)

1 reference

29 November 2017

7

1 reference

29 November 2017

Michel P Bihl

1

1 reference

29 November 2017

Karl Heinimann

2

1 reference

29 November 2017

Jochen J Rüdiger

3

1 reference

29 November 2017

Oliver Eickelberg

4

1 reference

29 November 2017

André P Perruchoud

5

1 reference

29 November 2017

Michael Tamm

6

1 reference

29 November 2017

1 July 2002

1 reference

American Journal of Respiratory Cell and Molecular Biology

29 November 2017

1 reference

29 November 2017

27

1 reference

29 November 2017

1

1 reference

29 November 2017

48-56

1 reference

Major role of the soluble interleukin-6/interleukin-6 receptor complex for the proliferation of interleukin-6-dependent human myeloma cell lines

29 November 2017

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.27.1.4637

Interleukin-6 dependent induction of the cyclin dependent kinase inhibitor p21WAF1/CIP1 is lost during progression of human malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.27.1.4637

Intracellular interleukin 6 mediates platelet-derived growth factor-induced proliferation of nontransformed cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.27.1.4637

Interleukin 6 and its relationship to clinical parameters in patients with malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.27.1.4637

The soluble interleukin-6 receptor is generated by shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.27.1.4637

Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.27.1.4637

Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.27.1.4637

Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.27.1.4637

Cell-mediated suppression of human interleukin-2 gene expression at splicing of mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.27.1.4637

Molecular model of an alternative splice variant of human IL-4, IL-4 delta 2, a naturally occurring inhibitor of IL-4-stimulated T cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.27.1.4637

Cell cultures from cryopreserved human lung tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.27.1.4637

Solution structure of recombinant human interleukin-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.27.1.4637

1.9 A crystal structure of interleukin 6: implications for a novel mode of receptor dimerization and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.27.1.4637

Platelet-activating factor exerts mitogenic activity and stimulates expression of interleukin 6 and interleukin 8 in human lung fibroblasts via binding to its functional receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.27.1.4637

The interleukin-4 family of lymphokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.27.1.4637

Interleukin-4 and Its Alternatively Spliced Variant (IL-4 δ 2) in Patients with Atopic Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.27.1.4637

21 January 2018

Identifiers

DOI

10.1165/AJRCMB.27.1.4637

1 reference

29 November 2017

1 reference